Patience Marime-Ball - Nov 4, 2021 Form 3 Insider Report for Intelligent Medicine Acquisition Corp. (IQMD)

Role
Director
Signature
/s/ Patience Marime-Ball
Stock symbol
IQMD
Transactions as of
Nov 4, 2021
Transactions value $
$0
Form type
3
Date filed
11/4/2021, 09:27 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IQMD Class B Common Stock Nov 4, 2021 Class A Common Stock 50K see footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As described in the issuer's registration statement on Form S-1 (File No. 333-260205) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination on a one-for-one basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like) and subject to certain anti-dilution rights and have no expiration date.
F2 Consists of 50,000 Class B Common Shares held by Women of the World Endowment, an entity the reporting person controls.

Remarks:

The reporting person has an indirect pecuniary interest in shares of Class B common stock of the issuer through membership interests in Intelligent Medicine Sponsor LLC over which the reporting person does not have voting or dispositive control